FDA Advisory Committee reviewed Imfinzi for resectable non-small cell lung cancer based on AEGEAN Phase III trial results Ruchika Sharma28 July 2024 4:15 PM ISTThe Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) has acknowledged that AstraZeneca's Imfinzi (durvalumab) met...
AstraZeneca concludes acquisition of Amolyt Pharma Ruchika Sharma17 July 2024 11:30 AM ISTCambridge: AstraZeneca has announced the successful completion of the acquisition of Amolyt Pharma, a clinical-stage biotechnology company...
Pfizer Chief Scientific Officer Dr Mikael Dolsten to depart Ruchika Sharma10 July 2024 2:30 PM ISTNew York: Pfizer Inc. has announced that Dr. Mikael Dolsten, Pfizer's Chief Scientific Officer and President, Pfizer Research & Development,...
AstraZeneca Tagrisso plus chemotherapy approved in EU for EGFR-mutated advanced lung cancer Ruchika Sharma8 July 2024 11:30 AM ISTCambridge: AstraZeneca has announced that Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy has been...
Lynparza, Imfinzi combo recommended for nod in EU by CHMP for endometrial cancer: AstraZeneca Ruchika Sharma3 July 2024 10:00 AM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) and Lynparza (olaparib) have been recommended for approval in the European Union (EU)...
Sipavibart EMA regulatory submission accepted under accelerated assessment for COVID 19 prevention: AsraZeneca Ruchika Sharma1 July 2024 5:33 PM ISTCambridge: AstraZeneca's Marketing Authorisation Application (MAA) for sipavibart has been accepted under an accelerated assessment procedure by...
AstraZeneca Imfinzi fails in late-stage trial to treat type of lung cancer Ruchika Sharma30 Jun 2024 11:30 AM ISTCambridge: AstraZeneca has announced the high-level results from the ADJUVANT BR.31 Phase III trial, sponsored by the Canadian Cancer Trials...
Expansion of warning statement may be considered after submission of first year PSUR data: CDSCO panel on AstraZeneca's anticancer drug Dr. Divya Colin25 Jun 2024 10:28 PM ISTNew Delhi: Noting that Tremelimumab Concentrate for Solution for infusion 20 mg/ml is not yet launched in the Indian market, the Subject Expert...
AstraZeneca Truqap, Faslodex combo approved in EU for advanced ER-positive breast cancer Ruchika Sharma21 Jun 2024 10:00 AM ISTCambridge: AstraZeneca has announced that Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the...
AstraZeneca Imfinzi plus chemotherapy gets USFDA nod for mismatch repair deficient advanced or recurrent endometrial cancer Ruchika Sharma17 Jun 2024 11:30 AM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) in combination with carboplatin and paclitaxel followed by Imfinzi monotherapy has...
AstraZeneca Farxiga gets USFDA nod for paediatric type 2 diabetes Ruchika Sharma14 Jun 2024 11:30 AM ISTCambridge: AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved Farxiga (dapagliflozin) for the improvement of...
AstraZeneca Tagrisso gets USFDA priority review for unresectable, Stage III EGFR-mutated lung cancer Ruchika Sharma11 Jun 2024 11:39 AM ISTAstraZeneca's supplemental New Drug Application (sNDA) for TAGRISSO (osimertinib) has been accepted and granted Priority Review in the US for the...
